Logo image of ALTRI.PA

TRILOGIQ (ALTRI.PA) Stock Fundamental Analysis

Europe - EPA:ALTRI - FR0010397901 - Common Stock

5.3 EUR
+0.05 (+0.95%)
Last: 10/24/2025, 7:00:00 PM
Fundamental Rating

5

Overall ALTRI gets a fundamental rating of 5 out of 10. We evaluated ALTRI against 106 industry peers in the Machinery industry. ALTRI is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. ALTRI is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year ALTRI was profitable.
In the past year ALTRI had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: ALTRI reported negative net income in multiple years.
Of the past 5 years ALTRI 4 years had a positive operating cash flow.
ALTRI.PA Yearly Net Income VS EBIT VS OCF VS FCFALTRI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025 0 5M -5M

1.2 Ratios

With a Return On Assets value of 2.53%, ALTRI perfoms like the industry average, outperforming 49.52% of the companies in the same industry.
The Return On Equity of ALTRI (2.80%) is worse than 62.86% of its industry peers.
ALTRI has a worse Return On Invested Capital (0.57%) than 77.14% of its industry peers.
Industry RankSector Rank
ROA 2.53%
ROE 2.8%
ROIC 0.57%
ROA(3y)1.54%
ROA(5y)N/A
ROE(3y)1.72%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALTRI.PA Yearly ROA, ROE, ROICALTRI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025 0 5 -5 -10 -15 -20

1.3 Margins

ALTRI has a better Profit Margin (4.57%) than 60.95% of its industry peers.
ALTRI's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 1.16%, ALTRI is doing worse than 77.14% of the companies in the same industry.
ALTRI's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 63.63%, ALTRI belongs to the top of the industry, outperforming 88.57% of the companies in the same industry.
In the last couple of years the Gross Margin of ALTRI has grown nicely.
Industry RankSector Rank
OM 1.16%
PM (TTM) 4.57%
GM 63.63%
OM growth 3Y17.04%
OM growth 5YN/A
PM growth 3Y25.71%
PM growth 5YN/A
GM growth 3Y1.99%
GM growth 5Y12.3%
ALTRI.PA Yearly Profit, Operating, Gross MarginsALTRI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025 0 20 -20 40 60

9

2. Health

2.1 Basic Checks

ALTRI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for ALTRI remains at a similar level compared to 1 year ago.
Compared to 5 years ago, ALTRI has about the same amount of shares outstanding.
The debt/assets ratio for ALTRI has been reduced compared to a year ago.
ALTRI.PA Yearly Shares OutstandingALTRI.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025 1M 2M 3M
ALTRI.PA Yearly Total Debt VS Total AssetsALTRI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025 20M 40M 60M

2.2 Solvency

ALTRI has an Altman-Z score of 5.57. This indicates that ALTRI is financially healthy and has little risk of bankruptcy at the moment.
ALTRI's Altman-Z score of 5.57 is amongst the best of the industry. ALTRI outperforms 94.29% of its industry peers.
The Debt to FCF ratio of ALTRI is 0.01, which is an excellent value as it means it would take ALTRI, only 0.01 years of fcf income to pay off all of its debts.
ALTRI has a better Debt to FCF ratio (0.01) than 100.00% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that ALTRI is not too dependend on debt financing.
ALTRI has a better Debt to Equity ratio (0.00) than 97.14% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Altman-Z 5.57
ROIC/WACC0.07
WACC8.15%
ALTRI.PA Yearly LT Debt VS Equity VS FCFALTRI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025 0 20M 40M

2.3 Liquidity

A Current Ratio of 9.71 indicates that ALTRI has no problem at all paying its short term obligations.
The Current ratio of ALTRI (9.71) is better than 99.05% of its industry peers.
A Quick Ratio of 8.58 indicates that ALTRI has no problem at all paying its short term obligations.
ALTRI's Quick ratio of 8.58 is amongst the best of the industry. ALTRI outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 9.71
Quick Ratio 8.58
ALTRI.PA Yearly Current Assets VS Current LiabilitesALTRI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025 10M 20M 30M 40M

1

3. Growth

3.1 Past

ALTRI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -32.65%.
The Earnings Per Share has been growing by 29.14% on average over the past years. This is a very strong growth
Looking at the last year, ALTRI shows a decrease in Revenue. The Revenue has decreased by -3.60% in the last year.
Measured over the past years, ALTRI shows a decrease in Revenue. The Revenue has been decreasing by -0.29% on average per year.
EPS 1Y (TTM)-32.65%
EPS 3Y29.14%
EPS 5YN/A
EPS Q2Q%-122.02%
Revenue 1Y (TTM)-3.6%
Revenue growth 3Y2.81%
Revenue growth 5Y-0.29%
Sales Q2Q%-14%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-2.78%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.12%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALTRI.PA Yearly Revenue VS EstimatesALTRI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
ALTRI.PA Yearly EPS VS EstimatesALTRI.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 -0.5 1 -1 1.5

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 18.28, the valuation of ALTRI can be described as rather expensive.
Compared to the rest of the industry, the Price/Earnings ratio of ALTRI indicates a somewhat cheap valuation: ALTRI is cheaper than 65.71% of the companies listed in the same industry.
ALTRI is valuated rather cheaply when we compare the Price/Earnings ratio to 26.89, which is the current average of the S&P500 Index.
ALTRI is valuated correctly with a Price/Forward Earnings ratio of 14.70.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ALTRI is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 22.99. ALTRI is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 18.28
Fwd PE 14.7
ALTRI.PA Price Earnings VS Forward Price EarningsALTRI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

80.95% of the companies in the same industry are more expensive than ALTRI, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 9
EV/EBITDA -23.34
ALTRI.PA Per share dataALTRI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ALTRI!.
Industry RankSector Rank
Dividend Yield N/A

TRILOGIQ

EPA:ALTRI (10/24/2025, 7:00:00 PM)

5.3

+0.05 (+0.95%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)07-24 2024-07-24/amc
Earnings (Next)N/A N/A
Inst Owners1.72%
Inst Owner ChangeN/A
Ins Owners76.77%
Ins Owner ChangeN/A
Market Cap19.82M
Revenue(TTM)23.20M
Net Income(TTM)1.06M
Analysts86.67
Price Target6.12 (15.47%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 18.28
Fwd PE 14.7
P/S 0.85
P/FCF 9
P/OCF 8.21
P/B 0.52
P/tB 0.52
EV/EBITDA -23.34
EPS(TTM)0.29
EY5.47%
EPS(NY)0.36
Fwd EY6.8%
FCF(TTM)0.59
FCFY11.11%
OCF(TTM)0.65
OCFY12.18%
SpS6.2
BVpS10.14
TBVpS10.13
PEG (NY)N/A
PEG (5Y)N/A
Graham Number8.13
Profitability
Industry RankSector Rank
ROA 2.53%
ROE 2.8%
ROCE 0.7%
ROIC 0.57%
ROICexc 1.67%
ROICexgc 1.67%
OM 1.16%
PM (TTM) 4.57%
GM 63.63%
FCFM 9.49%
ROA(3y)1.54%
ROA(5y)N/A
ROE(3y)1.72%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y31.78%
ROICexgc growth 5YN/A
ROICexc growth 3Y31.69%
ROICexc growth 5YN/A
OM growth 3Y17.04%
OM growth 5YN/A
PM growth 3Y25.71%
PM growth 5YN/A
GM growth 3Y1.99%
GM growth 5Y12.3%
F-Score6
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Debt/EBITDA 0.02
Cap/Depr 24.77%
Cap/Sales 0.91%
Interest Coverage 250
Cash Conversion 214.48%
Profit Quality 207.83%
Current Ratio 9.71
Quick Ratio 8.58
Altman-Z 5.57
F-Score6
WACC8.15%
ROIC/WACC0.07
Cap/Depr(3y)38.04%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.5%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-32.65%
EPS 3Y29.14%
EPS 5YN/A
EPS Q2Q%-122.02%
EPS Next Y-2.78%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.6%
Revenue growth 3Y2.81%
Revenue growth 5Y-0.29%
Sales Q2Q%-14%
Revenue Next Year5.12%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-68.86%
EBIT growth 3Y20.32%
EBIT growth 5YN/A
EBIT Next Year187.5%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-5.85%
FCF growth 3YN/A
FCF growth 5Y-4.81%
OCF growth 1Y-14.72%
OCF growth 3YN/A
OCF growth 5Y-3.83%

TRILOGIQ / ALTRI.PA FAQ

What is the ChartMill fundamental rating of TRILOGIQ (ALTRI.PA) stock?

ChartMill assigns a fundamental rating of 5 / 10 to ALTRI.PA.


What is the valuation status of TRILOGIQ (ALTRI.PA) stock?

ChartMill assigns a valuation rating of 4 / 10 to TRILOGIQ (ALTRI.PA). This can be considered as Fairly Valued.


Can you provide the profitability details for TRILOGIQ?

TRILOGIQ (ALTRI.PA) has a profitability rating of 4 / 10.


What are the PE and PB ratios of TRILOGIQ (ALTRI.PA) stock?

The Price/Earnings (PE) ratio for TRILOGIQ (ALTRI.PA) is 18.28 and the Price/Book (PB) ratio is 0.52.


Can you provide the financial health for ALTRI stock?

The financial health rating of TRILOGIQ (ALTRI.PA) is 9 / 10.